Caroline's Feed
Oct 2, 2015

US insurers hold back Lilly’s death-defying diabetes drug

NEW YORK, Oct 2 (Reuters) – America’s largest health
insurers are urging doctors to stick with current standard
treatments for diabetes instead of flocking to a new drug from
Eli Lilly & Co that is showing it can provide
life-saving results for one-third of patients.

Aetna Inc, CVS Health Corp and Molina
Healthcare Inc said they would need further clinical
data and a change in medical society guidelines on Lilly’s
Jardiance before agreeing to make it easier for patients to
receive the $4,800-a-year treatment. That’s a process that could
take anywhere from 18 months to several years.

Sep 24, 2015

Psychiatrists group warns U.S. DOJ insurance mergers could hurt care

NEW YORK (Reuters) – The American Psychiatric Association
warned U.S. antitrust regulators this month that two proposed
health insurance deals could worsen access to mental health care
services, adding to public opposition from several prominent
doctor groups.

Anthem Inc would become the largest U.S. health
insurer through a proposed $47 billion acquisition of Cigna
Corp, announced in late July. Earlier that month, Aetna
Inc said it would buy the Humana Inc to make it
the largest provider of Medicare plans for older people.

Sep 17, 2015

Perrigo recommends shareholders reject Mylan’s tender offer

By Caroline Humer

(Reuters) – Generic and over-the-counter drugmaker Perrigo Co Plc (PRGO.N: Quote, Profile, Research, Stock Buzz) on Thursday advised its shareholders to reject Mylan NV’s (MYL.O: Quote, Profile, Research, Stock Buzz) unsolicited $27 billion tender offer, saying it substantially undervalued the company.

Mylan first proposed to buy Perrigo in April and, after being repeatedly rebuffed, launched a tender offer on Monday.

Sep 17, 2015

Cigna CEO defends Anthem deal, says consumer will still have choice

NEW YORK (Reuters) – Health insurer Anthem’s planned $47 billion takeover of rival Cigna will not hurt consumers but increase choice and affordability, Cigna CEO David Cordani said, defending the merger against widespread criticism that it will harm competition.

The Anthem-Cigna deal and a plan by Aetna Inc to buy Humana have come in the wake of the implementation of the Affordable Care Act and amid pressure on insurers to keep healthcare spending down for their biggest customers – employers and the U.S. government.

Sep 8, 2015

U.S. doctors group says planned health mergers are anti-competitive

NEW YORK (Reuters) – The leading U.S. physicians’
organization said on Tuesday that two proposed mergers of U.S.
health insurers worth tens of billions of dollars could lead to
higher prices in 17 states for companies that buy insurance for
their workers or people who buy their own insurance.

Aetna Inc announced plans to buy smaller rival
Humana Inc in early July and Anthem Inc agreed
to buy Cigna Corp later that month. Both mergers are
being reviewed by the U.S. Department of Justice and state
insurance officials.

Sep 3, 2015

U.S. government to extend healthcare nondiscrimination law to transgender people

NEW YORK (Reuters) – The U.S. government said on Thursday it will extend its healthcare nondiscrimination law to transgender individuals and require health insurers and medical providers to treat all patients equally, regardless of sex.

The Affordable Care Act, also known as Obamacare, was passed in 2010 and included anti-discrimination provisions to prevent insurers from charging customers more or denying coverage based on age or sex.

Sep 3, 2015

U.S. govt to extend healthcare nondiscrimination law to transgender people

NEW YORK, Sept 3 (Reuters) – The U.S. government said on
Thursday it will extend its healthcare nondiscrimination law to
transgender individuals and require health insurers and medical
providers to treat all patients equally, regardless of sex.

The Affordable Care Act, also known as Obamacare, was passed
in 2010 and included anti-discrimination provisions to prevent
insurers from charging customers more or denying coverage based
on age or sex.

Aug 28, 2015

Mylan shareholders back Perrigo takeover, tender offer up next

NEW YORK (Reuters) – Mylan NV (MYL.O: Quote, Profile, Research, Stock Buzz) shareholders on Friday backed the drugmaker’s hostile bid for Perrigo Co (PRGO.N: Quote, Profile, Research, Stock Buzz), allowing it to launch a tender offer for the company’s shares in the next few weeks.

Mylan said that it had the support from investors representing a majority of shares, passing the threshold it needed to go directly to Perrigo shareholders. The company is now looking for holders of more than 50 percent of Perrigo’s shares to take part in the tender offer.

Aug 25, 2015

Perrigo CEO expects shareholders to reject Mylan bid

NEW YORK (Reuters) – Perrigo Co Plc’s (PRGO.N: Quote, Profile, Research, Stock Buzz) chief executive expressed confidence on Tuesday that his company’s shareholders will reject rival generic drugmaker Mylan NV’s hostile takeover attempt, and said the offer is not close to what it would take to get a deal done.

Mylan (MYL.O: Quote, Profile, Research, Stock Buzz) shareholders are set to vote on Friday on whether the company should move forward with the Perrigo bid, whose value has declined with the recent market sell-off. If more than half vote “yes,” Mylan plans to take its cash and stock offer directly to Perrigo shareholders.

Aug 14, 2015

Proxy firm urges Mylan investors vote ‘no'; Paulson backs deal

NEW YORK, Aug 14 (Reuters) – ISS Proxy Advisory Services
recommended on Friday that its clients vote against Mylan NV’s
$30 billion hostile takeover of Perrigo Co,
even as Mylan’s largest hedge fund investor put its money behind
the combination.

Paulson & Co, which owns a 4.6 percent stake in Mylan, said
it voted for the generic drugmaker to pursue its tender offer
for Perrigo shares.